NEW YORK (GenomeWeb News) — Agilent Technologies today said fiscal fourth-quarter revenues increased 6 percent as R&D spending fell 8 percent and profit surged 508 percent.
Total receipts for the three months ended Sept. 30 increased to $1.33 billion from $1.25 billion year over year.
Revenue for the company’s Bio-Analytical Measurement segment rose 9 percent to $418 million.
R&D spending decreased to $155 million from $168 million year over year.
The company said profit increased to $152 million from $25 million in the year-ago period, which included restructuring charges and other items.
Agilent said it had around $2.3 billion in cash and equivalents as of Sept. 30.
During the quarter, Agilent said its return on invested capital was at 29 percent, and the company issued a two-year, $2-billion stock repurchase program
The company said it expects fiscal first-quarter 2007 revenues to be between $1.25 billion and $1.29 billion, or between 7 percent and 10 percent better than the same quarter of 2006.